|
|
|
Genetic variability may predict severity of side effects from methotrexate, a common chemotherapy drug
Nearly half of all Americans carry a genetic mutation that interferes with their ability to metabolize folate. Such people, when exposed to a poor diet or certain drugs, can suffer significant clinical consequences, particularly if they are among the approximately 10 percent of Americans born ith the most limited abilty to process this nutrient. NIH/National Cancer Institute Contact:
Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Message posted by: Wouter Kalle
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|